Ledger.Open graph →
SEC Form D · filed August 17, 2020

Antios Therapeutics Inc

Offering
$5.0M
Sold
$4.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ATLANTA, GA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Idean Marvasty · Atlanta, GAExecDouglas L. Mayers · Atlanta, GAExecAbel De La Rosa · Atlanta, GAExec · DirectorNicole Vitullo · San Diego, CADirectorScott Morenstein · Atlanta, GADirectorHenry L. Chen · Grand Cayman, Cayman IslandsDirectorBenjamin Rovinski · Chapel Hill, NCDirectorIdean Marvasty · Atlanta, GAExecDouglas L. Mayers · Atlanta, GAExecAbel De La Rosa · Lawrenceville, GAExec · DirectorNicole Vitullo · BRANFORD, CTDirectorHenry L. Chen · Grand Cayman, Cayman IslandsDirectorBenjamin Rovinski · Chapel Hill, NCDirectorScott Morenstein · Malvern, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗